公开(公告)号：US11155832B2

公开(公告)日：2021-10-26

申请号：US16338075

申请日：2017-09-29

Applicant: GenVec, Inc.

Inventor： Sebastien M. Maloveste ,  Damodar Ettyreddy ,  Douglas E. Brough

IPC: C12N15/00 ,  A61K39/23 ,  C12N15/86 ,  C07K14/005

Abstract: The invention provides adenoviral vectors and compositions for the highly efficient transduction of T cells.

公开(公告)号：US20210301303A1

公开(公告)日：2021-09-30

申请号：US17229098

申请日：2021-04-13

Applicant: GenVec, Inc.

Inventor： Sebastien M. Maloveste ,  Damodar Ettyreddy ,  Douglas E. Brough

IPC: C12N15/86 ,  C07K14/005

Abstract: The invention provides adenoviral vectors and compositions for the highly efficient transduction of T cells.

公开(公告)号：US20190233845A1

公开(公告)日：2019-08-01

申请号：US16338075

申请日：2017-09-29

Applicant: GenVec, Inc.

Inventor： Sebastien M. Maloveste ,  Damodar Ettyreddy ,  Douglas E. Brough

IPC: C12N15/86

CPC classification number: C12N15/86 ,  C07K14/005 ,  C12N2710/10322 ,  C12N2710/10343

Abstract: The invention provides adenoviral vectors and compositions for the highly efficient transduction of T cells.